2seventy bio, Inc - TSVT Revenue Dynamics YoY (Last Twelve Months)

Graphic logo of 2seventy bio, Inc (TSVT)

Risks for 2seventy bio, Inc. (TSVT) are linked to the high cost of biomanufacturing and dependence on a key partner. The YoY sales growth over the last four quarters visualizes revenue dynamics, while the 184.00 value confirms the current trend level. The geopolitical backdrop remains neutral, ensuring the stability of clinical trials in the US. Innovation development efficiency is increasing by outsourcing production and testing to external contractors.

2seventy bio, Inc. (TSVT): Sales Growth YoY (TTM) from 02/11/2024 to 02/20/2024

2seventy bio, Inc (TSVT) - metric breakdowns and financial figures

- stock price and consensus target price:
Fundamental company valuation:2seventy bio, Inc.
Flagship merchandise of 2seventy Bio

This indicator measures the revenue growth rate over a rolling year, allowing for the identification of acceleration or deceleration in the business's operating cycle. Investors utilize the LTM YoY commercial revenue growth metric to assess model scalability, where steady growth confirms the efficiency of high-precision cellular material logistics and the reliability of 2seventy bio (TSVT) international supply chains.